A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)
NCT00772317 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 117
Last updated 2019-04-10
Summary
For the treatment of locally recurrent prostate cancer following failed external beam radiation therapy (EBRT)
Conditions
- Recurrent Prostate Cancer
Interventions
- DEVICE
-
High Intensity Focused Ultrasound
High Intensity Focused Ultrasound
Sponsors & Collaborators
-
SonaCare Medical
lead INDUSTRY
Principal Investigators
-
Mark Carol, MD · SonaCare Medical, LLC
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 40 Years
- Max Age
- 85 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-07-31
- Primary Completion
- 2020-12-31
- Completion
- 2021-12-31
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Evaluating the Safety and Efficacy of the "HIFU" High-intensity Focused Ultrasound Treatment of Benign Prostatic Hyperplasia;
NCT06601179 ·Status: RECRUITING ·Phase: NA
-
Ultrasound-Guided Photoselective Vaporization of the Prostate
NCT02346500 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia
NCT00077012 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
NCT06849258 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound.
NCT04853914 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Prostate Seed Implantation for Local Control of Early Stage Prostate Cancer
NCT00773305 ·Status: COMPLETED
-
A Pilot Study Of The ALPFA Benign Prostatic Hyperplasia (BPH) Pulsed Field Ablation (PFA) System
NCT06965582 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (Canada)
NCT01775488 ·Status: WITHDRAWN ·Phase: NA
-
Office Based Transperineal Laser Ablation for Benign Prostatic Hyperplasia HYPERPLASIA
NCT04760483 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Effects of TNF Blockade on Human BPH/LUTS
NCT06062875 ·Status: RECRUITING ·Phase: PHASE2
-
Study on the Effectiveness of Tranilast in the Treatment of Medium to Large Volume Benign Prostatic Hyperplasia
NCT06689514 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
One-year Prospective Observational Study of BMI Change Effect of 5-alpha Reductase Inhibitor in Korean BPH Patients
NCT00472251 ·Status: COMPLETED
-
Minimally Invasive Surgical Therapy for BPH
NCT00064649 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)
NCT01896973 ·Status: TERMINATED ·Phase: NA
-
RT-310 Dose Escalation BPH Study
NCT06136819 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Evaluation of the Functional Outcomes After Bilateral, 3D Ultrasound-guided Focal Thermal Ablation of the Prostate Transition Zone, in Patients with Benign Prostatic Hyperplasia-related Obstruction
NCT06212453 ·Status: RECRUITING ·Phase: PHASE2
-
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue II
NCT03123250 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness Study of the Zenflow Spring System
NCT04987138 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin
NCT00486785 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction
NCT00827814 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers
NCT02873117 ·Status: COMPLETED
-
A Long-Term Study Examining the Treatment of Benign Prostatic Hyperplasia With Photoselective Vaporization
NCT00465101 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Refractory Urinary Retention Secondary to Benign Prostatic Hyperplasia (BPH) With Dual Five Alpha Reductase Inhibition Combined With an Alpha Blocker
NCT00680680 ·Status: COMPLETED ·Phase: NA
-
Use of Autologous Adipose-Derived Stem/Stromal Cells (AD-cSVF) in Symptomatic Benign Prostate Hypertrophy
NCT02961114 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
A Study in Men With Benign Prostatic Hyperplasia
NCT01097707 ·Status: TERMINATED ·Phase: PHASE2